Taken together, knockdown of SHP2 prevented the P4-increased cSrcY416 and increased the level of cSrcY527 in the P4-treated breast cancer cell lines, suggesting that the presence of SHP2 played an important role in the P4-promoted breast cancer cell proliferation and migration. This evidence concerns the gene PTPN11 and breast carcinoma.